BSPM [Biostar Pharmaceuticals] 25-NSE: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]

By | 2019-01-09T04:31:48+00:00 January 8th, 2019|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 25-NSE: .FormData {color: blue; background-color: white; font-size: small; font-family:

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]

By | 2019-01-09T04:31:53+00:00 January 8th, 2019|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, August 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announc]

By | 2018-08-25T03:31:32+00:00 August 24th, 2018|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination

[Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, August 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announc]

By | 2018-08-25T03:31:38+00:00 August 24th, 2018|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China, July 25, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on July 19, 2018 it rece]

By | 2018-08-04T19:48:03+00:00 July 25th, 2018|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China,

[Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China, July 25, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on July 19, 2018 it rece]

By | 2018-08-04T19:48:10+00:00 July 25th, 2018|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): June 2, 2018 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, Pe]

By | 2018-07-07T03:31:08+00:00 July 6th, 2018|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): June 2, 2018 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, Pe]

By | 2018-07-07T03:31:12+00:00 July 6th, 2018|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] SC 13D: (Original Filing)

[SHARE PURCHASE AGREEMENT 股份购买协议 ____ "Seller" _____ "Purchaser" This Share Purchase Agreement (the "Agreement") is made as of the 4th day of June, 2018 by and between Ronghua Wang, with the People's Republic of China (the "PRC") Passport No. 2018 6 4 E85615992 (" ") K04837814 (" ") 本股份购买协议("本协议")于 W]

By | 2018-07-03T03:30:56+00:00 July 2nd, 2018|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] SC 13D: SHARE PURCHASE AGREEMENT 股份购买协议 ____ “Seller” _____ “Purchaser”

[SHARE PURCHASE AGREEMENT 股份购买协议 ____ "Seller" _____ "Purchaser" This Share Purchase Agreement (the "Agreement") is made as of the 4th day of June, 2018 by and between Ronghua Wang, with the People's Republic of China (the "PRC") Passport No. 2018 6 4 E85615992 (" ") K04837814 (" ") 本股份购买协议("本协议")于 W]

By | 2018-07-03T03:31:06+00:00 July 2nd, 2018|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar